世界の抗結核治療薬市場 2021：企業別、地域別、種類・用途別

• 英文タイトル：Global Anti-tuberculosis Medicine Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026

• レポートコード：GIR-202A2465 • 出版社/出版日：GlobalInfoResearch / 2021年12月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、110ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥522,000 (USD3,480)	▷ お問い合わせ
Multi User	￥783,000 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,044,000 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

当調査資料では、抗結核治療薬のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。抗結核治療薬の種類別市場規模（イソニアジド、リファンピン、エタンブトール、ピラジナミド、その他）、用途別市場規模（病院・診療所、政府機関、非営利団体、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・抗結核治療薬の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Lupin、Macleods Pharmaceuticals、Otsuka Pharmaceutical、Johnson & Johnson、Pfizer、Novartis、Abbott、AstraZeneca、Bayer、Eli Lilly、GlaxoSmithKline、Merck、Sanofi、Chongqing Huapont Pharm、Shuangding Pharm、Hongqi pharmaceutical ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：イソニアジド、リファンピン、エタンブトール、ピラジナミド、その他 ・用途別分析2016年-2026年：病院・診療所、政府機関、非営利団体、その他 ・抗結核治療薬の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・抗結核治療薬のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・抗結核治療薬のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・抗結核治療薬の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・抗結核治療薬の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論

The Anti-tuberculosis Medicine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Anti-tuberculosis Medicine size is estimated to be xx million in 2021 from USD xx million in 2020, with a change of XX% between 2020 and 2021. The global Anti-tuberculosis Medicine market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation
Anti-tuberculosis Medicine market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
Isoniazid
Rifampin
Ethambutol
Pyrazinamide
Otherr

Market segment by Application can be divided into
Hospitals and Clinics
Government Agencies
Non-Profit Organizations
Others

The key market players for global Anti-tuberculosis Medicine market are listed below:
Lupin
Macleods Pharmaceuticals
Otsuka Pharmaceutical
Johnson & Johnson
Pfizer
Novartis
Abbott
AstraZeneca
Bayer
Eli Lilly
GlaxoSmithKline
Merck
Sanofi
Chongqing Huapont Pharm
Shuangding Pharm
Hongqi pharmaceutical

Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 14 chapters:
Chapter 1, to describe Anti-tuberculosis Medicine product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Anti-tuberculosis Medicine, with price, sales, revenue and global market share of Anti-tuberculosis Medicine from 2019 to 2021.
Chapter 3, the Anti-tuberculosis Medicine competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Anti-tuberculosis Medicine breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2016 to 2026.
Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2016 to 2026.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and Anti-tuberculosis Medicine market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.
Chapter 12, 13 and 14, to describe Anti-tuberculosis Medicine sales channel, distributors, customers, research findings and conclusion, appendix and data source.

レポート目次

---

1 Market Overview
1.1 Anti-tuberculosis Medicine Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Anti-tuberculosis Medicine Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Isoniazid
1.2.3 Rifampin
1.2.4 Ethambutol
1.2.5 Pyrazinamide
1.2.6 Otherr
1.3 Market Analysis by Application
1.3.1 Overview: Global Anti-tuberculosis Medicine Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Hospitals and Clinics
1.3.3 Government Agencies
1.3.4 Non-Profit Organizations
1.3.5 Others
1.4 Global Anti-tuberculosis Medicine Market Size & Forecast
1.4.1 Global Anti-tuberculosis Medicine Sales in Value (2016-2026))
1.4.2 Global Anti-tuberculosis Medicine Sales in Volume (2016-2026)
1.4.3 Global Anti-tuberculosis Medicine Price by Type (2016-2026) & (US$/Ton)
1.5 Global Anti-tuberculosis Medicine Production Capacity Analysis
1.5.1 Global Anti-tuberculosis Medicine Total Production Capacity (2016-2026)
1.5.2 Global Anti-tuberculosis Medicine Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Anti-tuberculosis Medicine Market Drivers
1.6.2 Anti-tuberculosis Medicine Market Restraints
1.6.3 Anti-tuberculosis Medicine Trends Analysis
2 Manufacturers Profiles
2.1 Lupin
2.1.1 Lupin Details
2.1.2 Lupin Major Business
2.1.3 Lupin Anti-tuberculosis Medicine Product and Services
2.1.4 Lupin Anti-tuberculosis Medicine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.2 Macleods Pharmaceuticals
2.2.1 Macleods Pharmaceuticals Details
2.2.2 Macleods Pharmaceuticals Major Business
2.2.3 Macleods Pharmaceuticals Anti-tuberculosis Medicine Product and Services
2.2.4 Macleods Pharmaceuticals Anti-tuberculosis Medicine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.3 Otsuka Pharmaceutical
2.3.1 Otsuka Pharmaceutical Details
2.3.2 Otsuka Pharmaceutical Major Business
2.3.3 Otsuka Pharmaceutical Anti-tuberculosis Medicine Product and Services
2.3.4 Otsuka Pharmaceutical Anti-tuberculosis Medicine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.4 Johnson & Johnson
2.4.1 Johnson & Johnson Details
2.4.2 Johnson & Johnson Major Business
2.4.3 Johnson & Johnson Anti-tuberculosis Medicine Product and Services
2.4.4 Johnson & Johnson Anti-tuberculosis Medicine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.5 Pfizer
2.5.1 Pfizer Details
2.5.2 Pfizer Major Business
2.5.3 Pfizer Anti-tuberculosis Medicine Product and Services
2.5.4 Pfizer Anti-tuberculosis Medicine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.6 Novartis
2.6.1 Novartis Details
2.6.2 Novartis Major Business
2.6.3 Novartis Anti-tuberculosis Medicine Product and Services
2.6.4 Novartis Anti-tuberculosis Medicine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.7 Abbott
2.7.1 Abbott Details
2.7.2 Abbott Major Business
2.7.3 Abbott Anti-tuberculosis Medicine Product and Services
2.7.4 Abbott Anti-tuberculosis Medicine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.8 AstraZeneca
2.8.1 AstraZeneca Details
2.8.2 AstraZeneca Major Business
2.8.3 AstraZeneca Anti-tuberculosis Medicine Product and Services
2.8.4 AstraZeneca Anti-tuberculosis Medicine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.9 Bayer
2.9.1 Bayer Details
2.9.2 Bayer Major Business
2.9.3 Bayer Anti-tuberculosis Medicine Product and Services
2.9.4 Bayer Anti-tuberculosis Medicine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.10 Eli Lilly
2.10.1 Eli Lilly Details
2.10.2 Eli Lilly Major Business
2.10.3 Eli Lilly Anti-tuberculosis Medicine Product and Services
2.10.4 Eli Lilly Anti-tuberculosis Medicine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.11 GlaxoSmithKline
2.11.1 GlaxoSmithKline Details
2.11.2 GlaxoSmithKline Major Business
2.11.3 GlaxoSmithKline Anti-tuberculosis Medicine Product and Services
2.11.4 GlaxoSmithKline Anti-tuberculosis Medicine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.12 Merck
2.12.1 Merck Details
2.12.2 Merck Major Business
2.12.3 Merck Anti-tuberculosis Medicine Product and Services
2.12.4 Merck Anti-tuberculosis Medicine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.13 Sanofi
2.13.1 Sanofi Details
2.13.2 Sanofi Major Business
2.13.3 Sanofi Anti-tuberculosis Medicine Product and Services
2.13.4 Sanofi Anti-tuberculosis Medicine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.14 Chongqing Huapont Pharm
2.14.1 Chongqing Huapont Pharm Details
2.14.2 Chongqing Huapont Pharm Major Business
2.14.3 Chongqing Huapont Pharm Anti-tuberculosis Medicine Product and Services
2.14.4 Chongqing Huapont Pharm Anti-tuberculosis Medicine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.15 Shuangding Pharm
2.15.1 Shuangding Pharm Details
2.15.2 Shuangding Pharm Major Business
2.15.3 Shuangding Pharm Anti-tuberculosis Medicine Product and Services
2.15.4 Shuangding Pharm Anti-tuberculosis Medicine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.16 Hongqi pharmaceutical
2.16.1 Hongqi pharmaceutical Details
2.16.2 Hongqi pharmaceutical Major Business
2.16.3 Hongqi pharmaceutical Anti-tuberculosis Medicine Product and Services
2.16.4 Hongqi pharmaceutical Anti-tuberculosis Medicine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
3 Anti-tuberculosis Medicine Sales by Manufacturer
3.1 Global Anti-tuberculosis Medicine Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Anti-tuberculosis Medicine Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Anti-tuberculosis Medicine
3.4 Market Concentration Rate
3.4.1 Top 3 Anti-tuberculosis Medicine Manufacturer Market Share
3.4.2 Top 6 Anti-tuberculosis Medicine Manufacturer Market Share
3.5 Global Anti-tuberculosis Medicine Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Anti-tuberculosis Medicine Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Anti-tuberculosis Medicine Market Size by Region
4.1.1 Global Anti-tuberculosis Medicine Sales in Volume by Region (2016-2026)
4.1.2 Global Anti-tuberculosis Medicine Revenue by Region (2016-2026)
4.2 North America Anti-tuberculosis Medicine Revenue (2016-2026)
4.3 Europe Anti-tuberculosis Medicine Revenue (2016-2026)
4.4 Asia-Pacific Anti-tuberculosis Medicine Revenue (2016-2026)
4.5 South America Anti-tuberculosis Medicine Revenue (2016-2026)
4.6 Middle East and Africa Anti-tuberculosis Medicine Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Anti-tuberculosis Medicine Sales in Volume by Type (2016-2026)
5.2 Global Anti-tuberculosis Medicine Revenue by Type (2016-2026)
5.3 Global Anti-tuberculosis Medicine Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Anti-tuberculosis Medicine Sales in Volume by Application (2016-2026)
6.2 Global Anti-tuberculosis Medicine Revenue by Application (2016-2026)
6.3 Global Anti-tuberculosis Medicine Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Anti-tuberculosis Medicine Sales by Type (2016-2026)
7.2 North America Anti-tuberculosis Medicine Sales by Application (2016-2026)
7.3 North America Anti-tuberculosis Medicine Market Size by Country
7.3.1 North America Anti-tuberculosis Medicine Sales in Volume by Country (2016-2026)
7.3.2 North America Anti-tuberculosis Medicine Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Anti-tuberculosis Medicine Sales by Type (2016-2026)
8.2 Europe Anti-tuberculosis Medicine Sales by Application (2016-2026)
8.3 Europe Anti-tuberculosis Medicine Market Size by Country
8.3.1 Europe Anti-tuberculosis Medicine Sales in Volume by Country (2016-2026)
8.3.2 Europe Anti-tuberculosis Medicine Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Anti-tuberculosis Medicine Sales by Type (2016-2026)
9.2 Asia-Pacific Anti-tuberculosis Medicine Sales by Application (2016-2026)
9.3 Asia-Pacific Anti-tuberculosis Medicine Market Size by Region
9.3.1 Asia-Pacific Anti-tuberculosis Medicine Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Anti-tuberculosis Medicine Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Anti-tuberculosis Medicine Sales by Type (2016-2026)
10.2 South America Anti-tuberculosis Medicine Sales by Application (2016-2026)
10.3 South America Anti-tuberculosis Medicine Market Size by Country
10.3.1 South America Anti-tuberculosis Medicine Sales in Volume by Country (2016-2026)
10.3.2 South America Anti-tuberculosis Medicine Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Anti-tuberculosis Medicine Sales by Type (2016-2026)
11.2 Middle East & Africa Anti-tuberculosis Medicine Sales by Application (2016-2026)
11.3 Middle East & Africa Anti-tuberculosis Medicine Market Size by Country
11.3.1 Middle East & Africa Anti-tuberculosis Medicine Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Anti-tuberculosis Medicine Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Anti-tuberculosis Medicine Typical Distributors
12.3 Anti-tuberculosis Medicine Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer

List of Tables
Table 1. Global Anti-tuberculosis Medicine Revenue by Type, (USD Million), 2021-2026
Table 2. Global Anti-tuberculosis Medicine Revenue by Application, (USD Million), 2021-2026
Table 3. Lupin Basic Information, Manufacturing Base and Competitors
Table 4. Lupin Major Business
Table 5. Lupin Anti-tuberculosis Medicine Product and Services
Table 6. Lupin Anti-tuberculosis Medicine Sales (Kiliton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Macleods Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 8. Macleods Pharmaceuticals Major Business
Table 9. Macleods Pharmaceuticals Anti-tuberculosis Medicine Product and Services
Table 10. Macleods Pharmaceuticals Anti-tuberculosis Medicine Sales (Kiliton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Otsuka Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 12. Otsuka Pharmaceutical Major Business
Table 13. Otsuka Pharmaceutical Anti-tuberculosis Medicine Product and Services
Table 14. Otsuka Pharmaceutical Anti-tuberculosis Medicine Sales (Kiliton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 16. Johnson & Johnson Major Business
Table 17. Johnson & Johnson Anti-tuberculosis Medicine Product and Services
Table 18. Johnson & Johnson Anti-tuberculosis Medicine Sales (Kiliton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Pfizer Basic Information, Manufacturing Base and Competitors
Table 20. Pfizer Major Business
Table 21. Pfizer Anti-tuberculosis Medicine Product and Services
Table 22. Pfizer Anti-tuberculosis Medicine Sales (Kiliton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Novartis Basic Information, Manufacturing Base and Competitors
Table 24. Novartis Major Business
Table 25. Novartis Anti-tuberculosis Medicine Product and Services
Table 26. Novartis Anti-tuberculosis Medicine Sales (Kiliton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Abbott Basic Information, Manufacturing Base and Competitors
Table 28. Abbott Major Business
Table 29. Abbott Anti-tuberculosis Medicine Product and Services
Table 30. Abbott Anti-tuberculosis Medicine Sales (Kiliton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 32. AstraZeneca Major Business
Table 33. AstraZeneca Anti-tuberculosis Medicine Product and Services
Table 34. AstraZeneca Anti-tuberculosis Medicine Sales (Kiliton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Bayer Basic Information, Manufacturing Base and Competitors
Table 36. Bayer Major Business
Table 37. Bayer Anti-tuberculosis Medicine Product and Services
Table 38. Bayer Anti-tuberculosis Medicine Sales (Kiliton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 40. Eli Lilly Major Business
Table 41. Eli Lilly Anti-tuberculosis Medicine Product and Services
Table 42. Eli Lilly Anti-tuberculosis Medicine Sales (Kiliton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 44. GlaxoSmithKline Major Business
Table 45. GlaxoSmithKline Anti-tuberculosis Medicine Product and Services
Table 46. GlaxoSmithKline Anti-tuberculosis Medicine Sales (Kiliton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 47. Merck Basic Information, Manufacturing Base and Competitors
Table 48. Merck Major Business
Table 49. Merck Anti-tuberculosis Medicine Product and Services
Table 50. Merck Anti-tuberculosis Medicine Sales (Kiliton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 51. Sanofi Basic Information, Manufacturing Base and Competitors
Table 52. Sanofi Major Business
Table 53. Sanofi Anti-tuberculosis Medicine Product and Services
Table 54. Sanofi Anti-tuberculosis Medicine Sales (Kiliton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 55. Chongqing Huapont Pharm Basic Information, Manufacturing Base and Competitors
Table 56. Chongqing Huapont Pharm Major Business
Table 57. Chongqing Huapont Pharm Anti-tuberculosis Medicine Product and Services
Table 58. Chongqing Huapont Pharm Anti-tuberculosis Medicine Sales (Kiliton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 59. Shuangding Pharm Basic Information, Manufacturing Base and Competitors
Table 60. Shuangding Pharm Major Business
Table 61. Shuangding Pharm Anti-tuberculosis Medicine Product and Services
Table 62. Shuangding Pharm Anti-tuberculosis Medicine Sales (Kiliton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 63. Hongqi pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 64. Hongqi pharmaceutical Major Business
Table 65. Hongqi pharmaceutical Anti-tuberculosis Medicine Product and Services
Table 66. Hongqi pharmaceutical Anti-tuberculosis Medicine Sales (Kiliton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 67. Global Anti-tuberculosis Medicine Sales by Manufacturer (2019-2021e) & (Kiliton)
Table 68. Global Anti-tuberculosis Medicine Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 69. Market Position of Manufacturers in Anti-tuberculosis Medicine, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 70. Global Anti-tuberculosis Medicine Production Capacity by Company, (Kiliton): 2020 VS 2021
Table 71. Head Office and Anti-tuberculosis Medicine Production Site of Key Manufacturer
Table 72. Anti-tuberculosis Medicine New Entrant and Capacity Expansion Plans
Table 73. Anti-tuberculosis Medicine Mergers & Acquisitions in the Past Five Years
Table 74. Global Anti-tuberculosis Medicine Sales by Region (2016-2021e) & (Kiliton)
Table 75. Global Anti-tuberculosis Medicine Sales by Region (2021-2026) & (Kiliton)
Table 76. Global Anti-tuberculosis Medicine Revenue by Region (2016-2021e) & (USD Million)
Table 77. Global Anti-tuberculosis Medicine Revenue by Region (2021-2026) & (USD Million)
Table 78. Global Anti-tuberculosis Medicine Sales by Type (2016-2021e) & (Kiliton)
Table 79. Global Anti-tuberculosis Medicine Sales by Type (2021-2026) & (Kiliton)
Table 80. Global Anti-tuberculosis Medicine Revenue by Type (2016-2021e) & (USD Million)
Table 81. Global Anti-tuberculosis Medicine Revenue by Type (2021-2026) & (USD Million)
Table 82. Global Anti-tuberculosis Medicine Price by Type (2016-2021e) & (US$/Ton)
Table 83. Global Anti-tuberculosis Medicine Price by Type (2021-2026) & (US$/Ton)
Table 84. Global Anti-tuberculosis Medicine Sales by Application (2016-2021e) & (Kiliton)
Table 85. Global Anti-tuberculosis Medicine Sales by Application (2021-2026) & (Kiliton)
Table 86. Global Anti-tuberculosis Medicine Revenue by Application (2016-2021e) & (USD Million)
Table 87. Global Anti-tuberculosis Medicine Revenue by Application (2021-2026) & (USD Million)
Table 88. Global Anti-tuberculosis Medicine Price by Application (2016-2021e) & (US$/Ton)
Table 89. Global Anti-tuberculosis Medicine Price by Application (2021-2026) & (US$/Ton)
Table 90. North America Anti-tuberculosis Medicine Sales by Country (2016-2021e) & (Kiliton)
Table 91. North America Anti-tuberculosis Medicine Sales by Country (2021-2026) & (Kiliton)
Table 92. North America Anti-tuberculosis Medicine Revenue by Country (2016-2021e) & (USD Million)
Table 93. North America Anti-tuberculosis Medicine Revenue by Country (2021-2026) & (USD Million)
Table 94. North America Anti-tuberculosis Medicine Sales by Type (2016-2021e) & (Kiliton)
Table 95. North America Anti-tuberculosis Medicine Sales by Type (2021-2026) & (Kiliton)
Table 96. North America Anti-tuberculosis Medicine Sales by Application (2016-2021e) & (Kiliton)
Table 97. North America Anti-tuberculosis Medicine Sales by Application (2021-2026) & (Kiliton)
Table 98. Europe Anti-tuberculosis Medicine Sales by Country (2016-2021e) & (Kiliton)
Table 99. Europe Anti-tuberculosis Medicine Sales by Country (2021-2026) & (Kiliton)
Table 100. Europe Anti-tuberculosis Medicine Revenue by Country (2016-2021e) & (USD Million)
Table 101. Europe Anti-tuberculosis Medicine Revenue by Country (2021-2026) & (USD Million)
Table 102. Europe Anti-tuberculosis Medicine Sales by Type (2016-2021e) & (Kiliton)
Table 103. Europe Anti-tuberculosis Medicine Sales by Type (2021-2026) & (Kiliton)
Table 104. Europe Anti-tuberculosis Medicine Sales by Application (2016-2021e) & (Kiliton)
Table 105. Europe Anti-tuberculosis Medicine Sales by Application (2021-2026) & (Kiliton)
Table 106. Asia-Pacific Anti-tuberculosis Medicine Sales by Region (2016-2021e) & (Kiliton)
Table 107. Asia-Pacific Anti-tuberculosis Medicine Sales by Region (2021-2026) & (Kiliton)
Table 108. Asia-Pacific Anti-tuberculosis Medicine Revenue by Region (2016-2021e) & (USD Million)
Table 109. Asia-Pacific Anti-tuberculosis Medicine Revenue by Region (2021-2026) & (USD Million)
Table 110. Asia-Pacific Anti-tuberculosis Medicine Sales by Type (2016-2021e) & (Kiliton)
Table 111. Asia-Pacific Anti-tuberculosis Medicine Sales by Type (2021-2026) & (Kiliton)
Table 112. Asia-Pacific Anti-tuberculosis Medicine Sales by Application (2016-2021e) & (Kiliton)
Table 113. Asia-Pacific Anti-tuberculosis Medicine Sales by Application (2021-2026) & (Kiliton)
Table 114. South America Anti-tuberculosis Medicine Sales by Country (2016-2021e) & (Kiliton)
Table 115. South America Anti-tuberculosis Medicine Sales by Country (2021-2026) & (Kiliton)
Table 116. South America Anti-tuberculosis Medicine Revenue by Country (2016-2021e) & (USD Million)
Table 117. South America Anti-tuberculosis Medicine Revenue by Country (2021-2026) & (USD Million)
Table 118. South America Anti-tuberculosis Medicine Sales by Type (2016-2021e) & (Kiliton)
Table 119. South America Anti-tuberculosis Medicine Sales by Type (2021-2026) & (Kiliton)
Table 120. South America Anti-tuberculosis Medicine Sales by Application (2016-2021e) & (Kiliton)
Table 121. South America Anti-tuberculosis Medicine Sales by Application (2021-2026) & (Kiliton)
Table 122. Middle East & Africa Anti-tuberculosis Medicine Sales by Country (2016-2021e) & (Kiliton)
Table 123. Middle East & Africa Anti-tuberculosis Medicine Sales by Country (2021-2026) & (Kiliton)
Table 124. Middle East & Africa Anti-tuberculosis Medicine Revenue by Country (2016-2021e) & (USD Million)
Table 125. Middle East & Africa Anti-tuberculosis Medicine Revenue by Country (2021-2026) & (USD Million)
Table 126. Middle East & Africa Anti-tuberculosis Medicine Sales by Type (2016-2021e) & (Kiliton)
Table 127. Middle East & Africa Anti-tuberculosis Medicine Sales by Type (2021-2026) & (Kiliton)
Table 128. Middle East & Africa Anti-tuberculosis Medicine Sales by Application (2016-2021e) & (Kiliton)
Table 129. Middle East & Africa Anti-tuberculosis Medicine Sales by Application (2021-2026) & (Kiliton)
Table 130. Direct Channel Pros & Cons
Table 131. Indirect Channel Pros & Cons
Table 132. Anti-tuberculosis Medicine Typical Distributors
Table 133. Anti-tuberculosis Medicine Typical Customers
List of Figures
Figure 1. Anti-tuberculosis Medicine Picture
Figure 2. Global Anti-tuberculosis Medicine Sales Market Share by Type in 2020
Figure 3. Isoniazid
Figure 4. Rifampin
Figure 5. Ethambutol
Figure 6. Pyrazinamide
Figure 7. Otherr
Figure 8. Global Anti-tuberculosis Medicine Sales Market Share by Application in 2020
Figure 9. Hospitals and Clinics
Figure 10. Government Agencies
Figure 11. Non-Profit Organizations
Figure 12. Others
Figure 13. Global Anti-tuberculosis Medicine Market Size, (USD Million) & (Kiliton): 2020 VS 2021 VS 2026
Figure 14. Global Anti-tuberculosis Medicine Market Size and Forecast (2016-2026) & (USD Million)
Figure 15. Global Anti-tuberculosis Medicine Sales (2016-2026) & (Kiliton)
Figure 16. Global Anti-tuberculosis Medicine Price by Type (2016-2026) & (US$/Ton)
Figure 17. Global Anti-tuberculosis Medicine Production Capacity (2016-2026) & (Kiliton)
Figure 18. Global Anti-tuberculosis Medicine Production Capacity by Geographic Region: 2020 VS 2021
Figure 19. Anti-tuberculosis Medicine Market Drivers
Figure 20. Anti-tuberculosis Medicine Market Restraints
Figure 21. Anti-tuberculosis Medicine Market Trends
Figure 22. Global Anti-tuberculosis Medicine Sales Market Share by Manufacturer in 2020
Figure 23. Global Anti-tuberculosis Medicine Revenue Market Share by Manufacturer in 2020
Figure 24. Anti-tuberculosis Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 25. Top 3 Anti-tuberculosis Medicine Manufacturer (Revenue) Market Share in 2020
Figure 26. Top 6 Anti-tuberculosis Medicine Manufacturer (Revenue) Market Share in 2020
Figure 27. Global Anti-tuberculosis Medicine Sales Market Share by Region (2016-2026)
Figure 28. Global Anti-tuberculosis Medicine Revenue Market Share by Region (2016-2026)
Figure 29. North America Anti-tuberculosis Medicine Revenue (2016-2026) & (USD Million)
Figure 30. Europe Anti-tuberculosis Medicine Revenue (2016-2026) & (USD Million)
Figure 31. Asia-Pacific Anti-tuberculosis Medicine Revenue (2016-2026) & (USD Million)
Figure 32. South America Anti-tuberculosis Medicine Revenue (2016-2026) & (USD Million)
Figure 33. Middle East & Africa Anti-tuberculosis Medicine Revenue (2016-2026) & (USD Million)
Figure 34. Global Anti-tuberculosis Medicine Sales Market Share by Type (2016-2026)
Figure 35. Global Anti-tuberculosis Medicine Revenue Market Share by Type (2016-2026)
Figure 36. Global Anti-tuberculosis Medicine Price by Type (2016-2026) & (US$/Ton)
Figure 37. Global Anti-tuberculosis Medicine Sales Market Share by Application (2016-2026)
Figure 38. Global Anti-tuberculosis Medicine Revenue Market Share by Application (2016-2026)
Figure 39. Global Anti-tuberculosis Medicine Price by Application (2016-2026) & (US$/Ton)
Figure 40. North America Anti-tuberculosis Medicine Sales Market Share by Type (2016-2026)
Figure 41. North America Anti-tuberculosis Medicine Sales Market Share by Application (2016-2026)
Figure 42. North America Anti-tuberculosis Medicine Sales Market Share by Country (2016-2026)
Figure 43. North America Anti-tuberculosis Medicine Revenue Market Share by Country (2016-2026)
Figure 44. United States Anti-tuberculosis Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 45. Canada Anti-tuberculosis Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 46. Mexico Anti-tuberculosis Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 47. Europe Anti-tuberculosis Medicine Sales Market Share by Type (2016-2026)
Figure 48. Europe Anti-tuberculosis Medicine Sales Market Share by Application (2016-2026)
Figure 49. Europe Anti-tuberculosis Medicine Sales Market Share by Country (2016-2026)
Figure 50. Europe Anti-tuberculosis Medicine Revenue Market Share by Country (2016-2026)
Figure 51. Germany Anti-tuberculosis Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. France Anti-tuberculosis Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. United Kingdom Anti-tuberculosis Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. Russia Anti-tuberculosis Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. Italy Anti-tuberculosis Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. Asia-Pacific Anti-tuberculosis Medicine Sales Market Share by Region (2016-2026)
Figure 57. Asia-Pacific Anti-tuberculosis Medicine Sales Market Share by Application (2016-2026)
Figure 58. Asia-Pacific Anti-tuberculosis Medicine Sales Market Share by Region (2016-2026)
Figure 59. Asia-Pacific Anti-tuberculosis Medicine Revenue Market Share by Region (2016-2026)
Figure 60. China Anti-tuberculosis Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Japan Anti-tuberculosis Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. Korea Anti-tuberculosis Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. India Anti-tuberculosis Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. Southeast Asia Anti-tuberculosis Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. Australia Anti-tuberculosis Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. South America Anti-tuberculosis Medicine Sales Market Share by Type (2016-2026)
Figure 67. South America Anti-tuberculosis Medicine Sales Market Share by Application (2016-2026)
Figure 68. South America Anti-tuberculosis Medicine Sales Market Share by Country (2016-2026)
Figure 69. South America Anti-tuberculosis Medicine Revenue Market Share by Country (2016-2026)
Figure 70. Brazil Anti-tuberculosis Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 71. Argentina Anti-tuberculosis Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 72. Middle East & Africa Anti-tuberculosis Medicine Sales Market Share by Type (2016-2026)
Figure 73. Middle East & Africa Anti-tuberculosis Medicine Sales Market Share by Application (2016-2026)
Figure 74. Middle East & Africa Anti-tuberculosis Medicine Sales Market Share by Country (2016-2026)
Figure 75. Middle East & Africa Anti-tuberculosis Medicine Revenue Market Share by Country (2016-2026)
Figure 76. Turkey Anti-tuberculosis Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 77. Egypt Anti-tuberculosis Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 78. Saudi Arabia Anti-tuberculosis Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 79. South Africa Anti-tuberculosis Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 80. Sales Channel: Direct Channel vs Indirect Channel
Figure 81. Methodology
Figure 82. Research Process and Data Source

---